ALK EML4-ALK L1196M在非小细胞肺癌患者中,表现出EML4-ALK融合,L1196M已被证明对环唑替尼具有耐药性。EML4-ALK C1156Y\U0026 L1196M患者也是如此。 |
---|
别名
突变位点
Ref. Build: GRCh37 Ensembl Version: 75
Chr. | Start | Stop | Ref. s | Var. Bases |
2 | 29443631 | 29443631 | G | T |
Transcript | ||||
ENST00000389048.3 |
基因序列
ENST00000389048.3:c.3586C>003eA
NC_000002.11:g.29443631G>003eT
NM_004304.4:c.3586C>003eA
NP_004295.2:p.Leu1196Met
NC_000002.11:g.29443631G>003eT
NM_004304.4:c.3586C>003eA
NP_004295.2:p.Leu1196Met